𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Charcot–Marie–Tooth disease type 2D with a novel glycyl-tRNA synthetase gene (GARS) mutation

✍ Scribed by Ayumi Hamaguchi; Chiho Ishida; Kazuo Iwasa; Akiko Abe; Masahito Yamada


Publisher
Springer
Year
2010
Tongue
English
Weight
255 KB
Volume
257
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


A Recurrent loss-of-function alanyl-tRNA
✍ Heather M. McLaughlin; Reiko Sakaguchi; William Giblin; NIH Intramural Sequencin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 1 views

Charcot-Marie-Tooth (CMT) disease comprises a heterogeneous group of peripheral neuropathies characterized by muscle weakness and wasting, and impaired sensation in the extremities. Four genes encoding an aminoacyl-tRNA synthetase (ARS) have been implicated in CMT disease. ARSs are ubiquitously expr

A Novel Mutation (D305V) in the early gr
✍ Emilia Bellone; Emilio Di Maria; Silvia Soriani; Alessandra Varese; Laura Lamba 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 18 KB 👁 3 views

Hereditary motor and sensory neuropathies (HMSN) comprises a wide clinical spectrum of related disorders with defects in peripheral nerve myelination. Charcot-Marie-Tooth type 1 (CMT1) is the most common form and is usually a mild disease with onset in the first or second decade; however there is a

Charcot–marie–tooth disease with interme
✍ Isabel Banchs; Carlos Casasnovas; Jordi Montero; Victor Volpini; Juan Antonio Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB

## Abstract Charcot–Marie–Tooth (CMT) disease is a heterogeneous group of inherited sensory and motor neuropathies. Mutations in the gene that encodes for myelin protein zero (__MPZ__) can produce different phenotypes: CMT1 (with low conduction velocities), CMT2 (less frequent and with unaffected c